Pharma & Biotech

A trio of strategic announcements propelled Amazon shares sharply higher on Friday, with the stock climbing 5.6 percent to close...

The coming weeks will be critical for Bayer as two distinct but significant timelines—one legal, one financial—reach pivotal moments. While...

Investors are placing a significant bet on the iShares MSCI World ETF (URTH) even as it navigates a complex web...

Eli Lilly & Co. is executing a multi-billion dollar expansion on two critical fronts, yet its stock performance tells a...

NurExone Biologic has taken a significant step in its US expansion strategy by forming a new alliance. The company's subsidiary,...

Hydreight Technologies is accelerating the growth of its digital health platform through a dual focus on technological advancement and strategic...

Market confidence in BioNTech is being tested as analysts from prominent firms revise their outlooks downward. Leerink Partners has taken...

For years, Novo Nordisk’s financial performance was powered by premium pricing and overwhelming demand for its weight-loss injections, which consistently...

April marks a critical juncture for Bayer, the Leverkusen-based life sciences conglomerate, as two major events converge. While the company's...

The pharmaceutical packaging group Gerresheimer finds itself in a precarious financial position, despite projecting billions in revenue for the current...